Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Mohamed Attauabi, Camilla Höglund, Janne Fassov, Kenneth Bo Pedersen, Heidi Bansholm Hansen, Signe Wildt, Michael Dam Jensen, Anders Neumann, Cecilie Lind, Henrik Albaek Jacobsen, Ana-Maria Popa, Jens Kjeldsen, Natalia Pedersen, Akbar Molazahi, Kent Haderslev, Claus Aalykke, Torben Knudsen, Wojciech Cebula, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2021) Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases. Scandinavian Journal of Gastroenterology 56:9, pages 1040-1048.
Read now
Read now
Noritaka Takatsu, Takashi Hisabe, Daijiro Higashi, Toshiharu Ueki & Toshiyuki Matsui. (2020) Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy. Core Evidence 15, pages 7-20.
Read now
Read now
Marjorie Argollo, Gionata Fiorino, Laurent Peyrin-Biroulet & Silvio Danese. (2018) Vedolizumab for the treatment of Crohn’s disease. Expert Review of Clinical Immunology 14:3, pages 179-189.
Read now
Read now
Leon P. McLean & Raymond K. Cross. (2016) Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis. Expert Opinion on Drug Metabolism & Toxicology 12:7, pages 833-842.
Read now
Read now
Leon P. McLean & Raymond K. Cross. (2016) Integrin antagonists as potential therapeutic options for the treatment of Crohn’s disease. Expert Opinion on Investigational Drugs 25:3, pages 263-273.
Read now
Read now
Hongwei Guo, Yabin Cheng, Jerry Shapiro & Kevin McElwee. (2015) The role of lymphocytes in the development and treatment of alopecia areata. Expert Review of Clinical Immunology 11:12, pages 1335-1351.
Read now
Read now
Leah Gilroy & Patrick B Allen. (2014) Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?. Clinical and Experimental Gastroenterology 7, pages 163-172.
Read now
Read now
Daniela Gilardi, Gionata Fiorino, Marco Genua, Mariangela Allocca & Silvio Danese. (2014) Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?. Expert Review of Gastroenterology & Hepatology 8:7, pages 835-846.
Read now
Read now
Monica Cesarini & Gionata Fiorino. (2013) Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease – an update. Expert Review of Clinical Immunology 9:4, pages 301-306.
Read now
Read now
Nilanjan Ghosh, Rituparna Chaki & Subhash C. Mandal. (2012) Inhibition of Selective Adhesion Molecules in Treatment of Inflammatory Bowel Disease. International Reviews of Immunology 31:5, pages 410-427.
Read now
Read now
Stephen B Hanauer & Daan W Hommes. (2010) Inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 499-500.
Read now
Read now
Articles from other publishers (22)
Igor Tvaroška, Stanislav Kozmon & Juraj Kóňa. (2023) Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review. Cells 12:2, pages 324.
Crossref
Crossref
Mohamed Attauabi, Gorm Roager Madsen, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2022) Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis. Digestive and Liver Disease 54:9, pages 1168-1178.
Crossref
Crossref
Wenshuo Chen, Haijin Chen, Shudan Fu, Xiaohua Lin, Zheng Zheng & Jinlong Zhang. (2020) Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights. Bioprocess and Biosystems Engineering 44:5, pages 929-939.
Crossref
Crossref
Gionata Fiorino, Silvio Danese, Giovanni Giacobazzi & Antonino Spinelli. (2021) Medical therapy versus surgery in moderate-to-severe ulcerative colitis. Digestive and Liver Disease 53:4, pages 403-408.
Crossref
Crossref
Aurelien Amiot, Melanie Serrero, Laurent Peyrin-Biroulet, Jerome Filippi, Benjamin Pariente, Xavier Roblin, Anthony Buisson, Carmen Stefanescu, Caroline Trang-Poisson, Romain Altwegg, Philippe Marteau, Thibaud Vaysse, Anne Bourrier, Stephane Nancey, David Laharie, Matthieu Allez, Guillaume Savoye, Jacques Moreau, Lucine Vuitton, Stephanie Viennot, Guillaume Bouguen, Vered Abitbol, Mathurin Fumery, Charlotte Gagniere & Yoram Bouhnik. (2019) Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study. Alimentary Pharmacology & Therapeutics 50:1, pages 40-53.
Crossref
Crossref
Kenechukwu O Chudy-Onwugaje, Kaci E Christian, Francis A Farraye & Raymond K Cross. (2019) A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. Inflammatory Bowel Diseases 25:5, pages 820-830.
Crossref
Crossref
Carlos R Camara-Lemarroy, Luanne Metz, Jonathan B Meddings, Keith A Sharkey & V Wee Yong. (2018) The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain 141:7, pages 1900-1916.
Crossref
Crossref
Maria Lia Scribano. (2018) Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence. World Journal of Gastroenterology 24:23, pages 2457-2467.
Crossref
Crossref
S. Tadbiri, L. Peyrin-Biroulet, M. Serrero, J. Filippi, B. Pariente, X. Roblin, A. Buisson, C. Stefanescu, C. Trang-Poisson, R. Altwegg, P. Marteau, T. Vaysse, A. Bourrier, S. Nancey, D. Laharie, M. Allez, G. Savoye, C. Gilletta, C. Gagniere, L. Vuitton, S. Viennot, A. Aubourg, A.-L. Pelletier, G. Bouguen, V. Abitbol, M. Fumery, P. Claudepierre, Y. Bouhnik & A. Amiot. (2018) Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort. Alimentary Pharmacology & Therapeutics 47:4, pages 485-493.
Crossref
Crossref
A. Amiot, M. Serrero, L. Peyrin-Biroulet, J. Filippi, B. Pariente, X. Roblin, A. Buisson, C. Stefanescu, C. Trang-Poisson, R. Altwegg, P. Marteau, T. Vaysse, A. Bourrier, S. Nancey, D. Laharie, M. Allez, G. Savoye, J. Moreau, L. Vuitton, S. Viennot, A. Aubourg, A.-L. Pelletier, G. Bouguen, V. Abitbol, C. Gagniere & Y. Bouhnik. (2017) One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study. Alimentary Pharmacology & Therapeutics 46:3, pages 310-321.
Crossref
Crossref
Eugeni Domènech & Javier P. Gisbert. (2016) Eficacia y seguridad de vedolizumab en el tratamiento de la colitis ulcerosa. Gastroenterología y Hepatología 39:10, pages 677-686.
Crossref
Crossref
Eugeni Domènech & Javier P. Gisbert. (2016) Efficacy and safety of vedolizumab in the treatment of ulcerative colitis. Gastroenterología y Hepatología (English Edition) 39:10, pages 677-686.
Crossref
Crossref
Aurelien Amiot, Jean-Charles Grimaud, Laurent Peyrin-Biroulet, Jerome Filippi, Benjamin Pariente, Xavier Roblin, Anthony Buisson, Carmen Stefanescu, Caroline Trang-Poisson, Romain Altwegg, Philippe Marteau, Thibaud Vaysse, Anne Bourrier, Stephane Nancey, David Laharie, Matthieu Allez, Guillaume Savoye, Jacques Moreau, Charlotte Gagniere, Lucine Vuitton, Stephanie Viennot, Alexandre Aubourg, Anne-Laure Pelletier, Guillaume Bouguen, Vered Abitbol, Yoram Bouhnik, Aurelien Amiot, Charlotte Gagniere, Jean-Charles Grimaud, Laurent Peyrin-Biroulet, Camille Zallot, Marc-Andre Bigard, Jerome Filippi, Xavier Hebuterne, Benjamin Pariente, Maria Nachury, Pierre Desreumaux, Xavier Roblin, Emilie Del Tedesco, Anthony Buisson, Gilles Bommelaer, Carmen Stefanescu, Arnaud Boureille, Caroline Trang-Poisson, Romain Altwegg, Philippe Marteau, Xavier Dray, Franck Carbonnel, Philippe Seksik, Laurent Beaugerie, Jacques Cosnes, Harry Sokol, Cecilia Landman, Stephane Nancey, Gilles Boschetti, David Laharie, Florian Poullenot, Matthieu Allez, Jean-Marc Gornet, Clautilde Baudry, Guillaume Savoye, Jacques Moreau, Charlotte Gagniere, Lucine Vuitton, Stephane Koch, Stephanie Viennot, Alexandre Aubourg, Laurence Picon, Anne-Laure Pelletier, Gaelle Sickersen, Guillaume Bouguen, Vered Abitbol, Stanislas Chaussade, Yoram Bouhnik, Stephane Nahon, Betsy Winkfield, Hedia Brixi-Benmansour, Rodica Gincul, Jean-Christophe Barberis, Bruno Bonaz, Christophe Michiels, Franck Zerbib, Marie Bourrier de Beauregard, Christophe Locher, Sophie Davin-Couve, Armelle Poirette, Laurence Guillem, Monica Stetiu-Mocanu, Sylvain Beorchia & Jawad Al Qaddi. (2016) Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 14:11, pages 1593-1601.e2.
Crossref
Crossref
Gionata Fiorino, Daniela Gilardi & Silvio Danese. (2016) The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes. Therapeutic Advances in Gastroenterology 9:4, pages 503-512.
Crossref
Crossref
Javier P. Gisbert & Eugeni Domènech. (2015) Vedolizumab en el tratamiento de la enfermedad de Crohn. Gastroenterología y Hepatología 38:5, pages 338-348.
Crossref
Crossref
Jerzy W. Kupiec-Weglinski, Yuan Zhai, Ana J. Coito, Henrik Petrowsky, Johnny C. Hong & Ronald W. Busuttil. 2015. Transplantation of the Liver. Transplantation of the Liver
1438
1451
.
Silvia D’Alessio, Carlotta Tacconi, Claudio Fiocchi & Silvio Danese. (2013) Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Current Opinion in Gastroenterology 29:6, pages 608-613.
Crossref
Crossref
Mahmoud H Mosli & Brian G Feagan. (2012) The emerging role of vedolizumab in the treatment of ulcerative colitis. Clinical Investigation 2:12, pages 1201-1212.
Crossref
Crossref
S. Duarte, X.-D. Shen, C. Fondevila, R.W. Busuttil & A.J. Coito. (2012) Fibronectin-α4β1 Interactions in Hepatic Cold Ischemia and Reperfusion Injury: Regulation of MMP-9 and MT1-MMP via the p38 MAPK Pathway. American Journal of Transplantation 12:10, pages 2689-2699.
Crossref
Crossref
Leon P McLean, Terez Shea-Donohue & Raymond K Cross. (2012) Vedolizumab for the treatment of ulcerative colitis and Crohn’s disease. Immunotherapy 4:9, pages 883-898.
Crossref
Crossref
Asit Parikh, Timothy Leach, Tim Wyant, Catherine Scholz, Serap Sankoh, Diane R. Mould, Terry Ponich, Irving Fox & Brian G. Feagan. (2012) Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study. Inflammatory Bowel Diseases 18:8, pages 1470-1479.
Crossref
Crossref
Ana J Coito. (2011) Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury. Current Opinion in Organ Transplantation 16:1, pages 34-40.
Crossref
Crossref